Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs3814113
rs3814113 		0.820 GeneticVariation BEFREE To assess the potential implications of microRNAs in ovarian cancer, we investigated the associations between microRNA expression and seven ovarian cancer risk variants discovered from genome-wide association studies (GWAS), namely, rs3814113 on 9p22.2, rs2072590 on 2q31, rs2665390 on 3q25, rs10088218, rs1516982, rs10098821 on 8q24.21 and rs2363956 on 19p13. 22235027

2012
dbSNP: rs3814113
rs3814113 		T 0.820 GeneticVariation GWASCAT The most significant SNP (rs3814113; P = 2.5 x 10(-17)) was genotyped in a further 2,670 ovarian cancer cases and 4,668 controls, confirming its association (combined data odds ratio (OR) = 0.82, 95% confidence interval (CI) 0.79-0.86, P(trend) = 5.1 x 10(-19)). 19648919

2009
dbSNP: rs3814113
rs3814113 		A 0.820 GeneticVariation GWASDB Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. 23544013

2013
dbSNP: rs3814113
rs3814113 		A 0.820 GeneticVariation GWASCAT Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. 23544013

2013
dbSNP: rs3814113
rs3814113 		0.820 GeneticVariation GWASCAT GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013
dbSNP: rs3814113
rs3814113 		0.820 GeneticVariation BEFREE A genome-wide association study recently identified an association between the rare allele of the single-nucleotide polymorphism (SNP) rs3814113 (ie, the C allele) at 9p22.2 and decreased risk of ovarian cancer for women in the general population. 21169536

2011
dbSNP: rs4691139
rs4691139 		G 0.800 GeneticVariation GWASCAT In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4 × 10(-8), HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4 × 10(-8), HR = 1.20, 95% CI: 1.17-1.38). 23544013

2013
dbSNP: rs4691139
rs4691139 		G 0.800 GeneticVariation GWASCAT Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. 28346442

2017
dbSNP: rs4691139
rs4691139 		G 0.800 GeneticVariation GWASDB In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4 × 10(-8), HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4 × 10(-8), HR = 1.20, 95% CI: 1.17-1.38). 23544013

2013
dbSNP: rs10674174
rs10674174 		0.700 GeneticVariation GWASCAT Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence. 27047539

2016
dbSNP: rs10899426
rs10899426 		0.700 GeneticVariation GWASCAT Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. 28935272

2017
dbSNP: rs10962692
rs10962692 		G 0.700 GeneticVariation GWASCAT Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. 28346442

2017
dbSNP: rs111970895
rs111970895 		0.700 GeneticVariation GWASCAT Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women. 30898391

2019
dbSNP: rs115707823
rs115707823 		A 0.700 GeneticVariation GWASCAT Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. 27197191

2016
dbSNP: rs11907546
rs11907546 		C 0.700 GeneticVariation GWASCAT Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. 27197191

2016
dbSNP: rs12025262
rs12025262 		0.700 GeneticVariation GWASCAT Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence. 27047539

2016
dbSNP: rs12031579
rs12031579 		G 0.700 GeneticVariation GWASCAT Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1. 30557369

2018
dbSNP: rs137672
rs137672 		C 0.700 GeneticVariation GWASCAT We conducted GWAS for ovarian cancer using 681 Japanese cases and 17,492 controls and found that rs137672 on 22q13.1 exhibited a strong association with a P-value of 1.05 × 10(-7) and an odds ratio of 0.573 with a 95% confidence interval of 0.466-0.703. 30557369

2018
dbSNP: rs141752671
rs141752671 		G 0.700 GeneticVariation GWASCAT Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. 27197191

2016
dbSNP: rs144199732
rs144199732 		0.700 GeneticVariation GWASCAT Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women. 30898391

2019
dbSNP: rs145065165
rs145065165 		G 0.700 GeneticVariation GWASCAT Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1. 30557369

2018
dbSNP: rs147527678
rs147527678 		C 0.700 GeneticVariation GWASCAT Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. 27197191

2016
dbSNP: rs147680653
rs147680653 		G 0.700 GeneticVariation GWASCAT Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. 27197191

2016
dbSNP: rs148883465
rs148883465 		G 0.700 GeneticVariation GWASCAT Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. 27197191

2016
dbSNP: rs169225
rs169225 		0.700 GeneticVariation GWASCAT Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women. 30898391

2019